- Home
- / Tizona Therapeutics
Tizona Therapeutics
Total Funding
$70 M
Tizona Therapeutics Summary
Company Summary
- Overview
- Tizona Therapeutics is an immunology company which develops treatments for cancer and autoimmune diseases. Its main products are anti-ccr4 antibody for the treatment of cancer and IL-35 agonists for the treatment of autoimmune diseases.
- Type
- Private
- Status
- Active
- Founded
- 2014
- HQ
- South San Francisco, CA, US | view all locations
- Website
- http://tizonatx.com/
- Cybersecurity rating
Table of Contents
Key People
Christine O'Brien, Chief Executive Officer, Director
Pankaj Bhargava, Director
Dan Spiegelman, Director
LocationsView all
1 location detected
South San Francisco, CA HQ
United States
4000 Shoreline Ct #200South